Home > Boards > US Listed > Biotechs > Teva Pharmaceutical (TEVA)

TEVA, PFE settle US Viagra-patent litigation: #msg-95062675.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 742
Posts 114,324
Boards Moderated 15
Alias Born 09/05/02
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 7:01:16 AM
Teva Reports Third Quarter 2020 Financial Results Business Wire - 11/5/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/3/2020 7:43:10 AM
Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio Business Wire - 10/21/2020 8:00:00 AM
Shield Therapeutics: Peer Teva Pharmaceutical Industries Withdraws Oppositions to Patents Dow Jones News - 10/19/2020 3:14:00 AM
iBio Announces Appointment of Dr. Alexandra Kropotova to Board of Directors GlobeNewswire Inc. - 10/15/2020 7:30:10 AM
Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfr... Business Wire - 10/7/2020 8:00:00 AM
Teva Canada annonce la mise en marché d'Aermony RespiClickMC, un nouveau dispositif novateur dans le traitement de l'asthme ... PR Newswire (Canada) - 10/5/2020 8:00:00 AM
Teva Canada annonce la mise en marché d’Aermony RespiClickMC, un nouveau dispositif novateur dans le traitement de l’ast... Business Wire - 10/5/2020 8:00:00 AM
Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma PR Newswire (Canada) - 10/5/2020 8:00:00 AM
Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg... Business Wire - 10/2/2020 8:00:00 AM
Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5, 2020 Business Wire - 10/1/2020 11:06:00 AM
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate & salmeterol) Inhalation Powder ... Business Wire - 9/21/2020 8:00:00 AM
First Long-Term Data on the use of AJOVY® (fremanezumab-vfrm) Injection in Patients with Migraine Published in Neurology Business Wire - 9/15/2020 8:00:00 AM
Teva to Present New Data at The MDS Virtual Congress 2020 & Psych Congress 2020 Virtual Experience Evaluating Long-Term Treat... Business Wire - 9/14/2020 8:00:00 AM
Teva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at the MDS Virtual Congress 2020 & Psych Congress 2020 Virtu... Business Wire - 9/8/2020 8:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/3/2020 4:10:25 PM
Indictment Came After Failed DOJ, Teva Talks -- WSJ Dow Jones News - 8/28/2020 3:02:00 AM
Teva's Indictment Came After Talks Faltered with Justice Department Dow Jones News - 8/27/2020 5:21:00 PM
Teva Indicted in Price Case -- WSJ Dow Jones News - 8/26/2020 3:02:00 AM
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges -- 4th Update Dow Jones News - 8/25/2020 10:14:00 PM
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges -- 3rd Update Dow Jones News - 8/25/2020 8:43:00 PM
Statement in Response to News of the Indictment of Teva USA Business Wire - 8/25/2020 8:39:00 PM
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges -- 2nd Update Dow Jones News - 8/25/2020 7:57:00 PM
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges -- Update Dow Jones News - 8/25/2020 6:57:00 PM
DewDiligence Member Level  Tuesday, 12/17/13 05:14:16 PM
Re: None
Post # of 3530 
TEVA, PFE settle US Viagra-patent litigation: #msg-95062675.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences